Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.03% |
| 2 | Technology | 3.4% |
| 3 | Healthcare | 3.08% |
| 4 | Financials | 2.41% |
| 5 | Consumer Discretionary | 2.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Republic Services
RSG
$64.9B
| $119M | 0.02% |
624,167
+169,845
| +37% | +$30.1M |
|
602
Texas Instruments
TXN
$254B
| $119M | 0.02% |
683,460
+282,180
| +70% | +$47.1M |
|
603
CALL
AstraZeneca
AZN
$258B
| $119M | 0.02% |
877,300
+281,550
| +47% | +$37.3M |
|
604
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$14.8B
| $119M | 0.02% |
1,527,928
-3,141,891
| -67% | -$243M |
|
605
ConocoPhillips
COP
$153B
| $118M | 0.02% |
929,411
-68,765
| -7% | -$7.84M |
|
606
CALL
Regeneron Pharmaceuticals
REGN
$81.1B
| $118M | 0.02% |
122,900
-118,500
| -49% | -$113M |
|
607
Strategy Inc
MSTR
$63B
| $117M | 0.02% |
+688,060
| New | +$62.7M |
|
608
CALL
KKR & Co
KKR
$86.8B
| $117M | 0.02% |
1,164,600
+380,300
| +48% | +$35M |
|
|
609
PUT
Gilead Sciences
GILD
$187B
| $117M | 0.02% |
1,597,100
+379,700
| +31% | +$29.2M |
|
610
PUT
RH
RH
$2.35B
| $117M | 0.02% |
335,500
-115,900
| -26% | -$31.6M |
|
611
CALL
Automatic Data Processing
ADP
$105B
| $116M | 0.02% |
466,400
+70,900
| +18% | +$17.3M |
|
612
Organon & Co
OGN
$3.61B
| $116M | 0.02% |
6,177,010
+1,966,914
| +47% | +$33.8M |
|
613
Neurocrine Biosciences
NBIX
$14.1B
| $116M | 0.02% |
841,318
+729,318
| +651% | +$99.6M |
|
614
MoonLake Immunotherapeutics
MLTX
$1.02B
| $116M | 0.02% |
2,309,433
+300,773
| +15% | +$16.3M |
|
615
PUT
Domino's
DPZ
$9.66B
| $116M | 0.02% |
233,300
-312,400
| -57% | -$136M |
|
616
PUT
VanEck Oil Services ETF
OIH
$2.03B
| $116M | 0.02% |
344,600
-61,700
| -15% | -$18.7M |
|
617
PUT
iShares US Real Estate ETF
IYR
$4.03B
| $116M | 0.02% |
1,288,700
-413,900
| -24% | -$36.6M |
|
618
CALL
Duke Energy
DUK
$88.4B
| $116M | 0.02% |
1,195,700
+157,000
| +15% | +$14.9M |
|
619
PUT
SoFi Technologies
SOFI
$21.4B
| $115M | 0.02% |
15,820,500
+7,949,700
| +101% | +$63.1M |
|
620
CALL
Dick's Sporting Goods
DKS
$13.4B
| $115M | 0.02% |
513,600
-4,500
| -0.9% | -$769K |
|
621
CALL
SLB Ltd
SLB
$76.5B
| $115M | 0.02% |
2,106,800
-320,500
| -13% | -$16.2M |
|
622
CALL
Estee Lauder
EL
$34.2B
| $115M | 0.02% |
748,400
-247,900
| -25% | -$35.2M |
|
|
623
PUT
AstraZeneca
AZN
$258B
| $115M | 0.02% |
848,700
+388,450
| +84% | +$51.4M |
|
624
MasTec
MTZ
$17.1B
| $114M | 0.02% |
1,217,344
+439,298
| +56% | +$33.4M |
|
625
CALL
Affirm
AFRM
$24.1B
| $113M | 0.02% |
3,046,100
+52,500
| +2% | +$2.1M |
|
Similar funds
Citadel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q1 2024 filing shows 1,747 new, 6,360 increased, 6,147 reduced and 1,438 closed positions. Its largest new stake was TD Synnex: 2,162,840 shares worth $245M. The largest sale was NVIDIA, an estimated $1.78B.
By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
- Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Citadel Advisors opened 1,747 new positions and closed 1,438 in Q1 2024.
- Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.